Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H K Ronday

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Annals of the Rheumatic Diseases|July 4, 2012
'Insights in the relationship of joint space narrowing versus erosive joint damage and physical functioning of patients with RA'R Koevoets, L Dirven, N B Klarenbeek, et al.
Rheumatology (Oxford, England)|February 7, 2001
Human granzyme B mediates cartilage proteoglycan degradation and is expressed at the invasive front of the synovium in rheumatoid arthritisH K Ronday, W H van der Laan, P P Tak, et al.
Arthritis Care & Research|June 11, 2010
Exploring the public health impact of an intensive exercise program for patients with rheumatoid arthritis: a dissemination and implementation studyF J van der Giesen, W van Lankveld, M Hopman-Rock, et al.
Rheumatology (Oxford, England)|April 11, 2008
Value of serum cartilage oligomeric matrix protein as a prognostic marker of large-joint damage in rheumatoid arthritis--data from the RAPIT studyZ de Jong, M Munneke, V Vilim, et al.
Annals of the Rheumatic Diseases|April 26, 2007
Bone mineral density in patients with recently diagnosed, active rheumatoid arthritisM Güler-Yüksel, J Bijsterbosch, Y P M Goekoop-Ruiterman, et al.
Arthritis and Rheumatism|April 29, 2008
Progression of joint damage in early rheumatoid arthritis: association with HLA-DRB1, rheumatoid factor, and anti-citrullinated protein antibodies in relation to different treatment strategiesJ K de Vries-Bouwstra, Y P M Goekoop-Ruiterman, K N Verpoort, et al.
Annals of the Rheumatic Diseases|July 30, 2008
Drug-free remission, functioning and radiographic damage after 4 years of response-driven treatment in patients with recent-onset rheumatoid arthritisS M van der Kooij, Y P M Goekoop-Ruiterman, J K de Vries-Bouwstra, et al.
Arthritis and Rheumatism|November 1, 2005
Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trialY P M Goekoop-Ruiterman, J K de Vries-Bouwstra, C F Allaart, et al.
Arthritis and Rheumatism|February 2, 2008
Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): A randomized, controlled trialY P M Goekoop-Ruiterman, J K de Vries-Bouwstra, C F Allaart, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Annals of the Rheumatic Diseases|July 4, 2012
'Insights in the relationship of joint space narrowing versus erosive joint damage and physical functioning of patients with RA'R Koevoets, L Dirven, N B Klarenbeek, et al.
Rheumatology (Oxford, England)|February 7, 2001
Human granzyme B mediates cartilage proteoglycan degradation and is expressed at the invasive front of the synovium in rheumatoid arthritisH K Ronday, W H van der Laan, P P Tak, et al.
Arthritis Care & Research|June 11, 2010
Exploring the public health impact of an intensive exercise program for patients with rheumatoid arthritis: a dissemination and implementation studyF J van der Giesen, W van Lankveld, M Hopman-Rock, et al.
Rheumatology (Oxford, England)|April 11, 2008
Value of serum cartilage oligomeric matrix protein as a prognostic marker of large-joint damage in rheumatoid arthritis--data from the RAPIT studyZ de Jong, M Munneke, V Vilim, et al.
Annals of the Rheumatic Diseases|April 26, 2007
Bone mineral density in patients with recently diagnosed, active rheumatoid arthritisM Güler-Yüksel, J Bijsterbosch, Y P M Goekoop-Ruiterman, et al.
Arthritis and Rheumatism|April 29, 2008
Progression of joint damage in early rheumatoid arthritis: association with HLA-DRB1, rheumatoid factor, and anti-citrullinated protein antibodies in relation to different treatment strategiesJ K de Vries-Bouwstra, Y P M Goekoop-Ruiterman, K N Verpoort, et al.
Annals of the Rheumatic Diseases|July 30, 2008
Drug-free remission, functioning and radiographic damage after 4 years of response-driven treatment in patients with recent-onset rheumatoid arthritisS M van der Kooij, Y P M Goekoop-Ruiterman, J K de Vries-Bouwstra, et al.
Arthritis and Rheumatism|November 1, 2005
Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trialY P M Goekoop-Ruiterman, J K de Vries-Bouwstra, C F Allaart, et al.
Arthritis and Rheumatism|February 2, 2008
Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): A randomized, controlled trialY P M Goekoop-Ruiterman, J K de Vries-Bouwstra, C F Allaart, et al.
Pageof 4